miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer

[1]  Yunli Zhou,et al.  miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer , 2019, Technology in cancer research & treatment.

[2]  Jianguo Shi,et al.  lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206/VEGF axis , 2019, Molecular medicine reports.

[3]  Yingyi Wang,et al.  MicroRNA-206 attenuates glioma cell proliferation, migration, and invasion by blocking the WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA. , 2019, American journal of translational research.

[4]  Kai Liu,et al.  miR-206 regulates alveolar type II epithelial cell Cx43 expression in sepsis-induced acute lung injury , 2019, Experimental and therapeutic medicine.

[5]  Xiaopeng Li,et al.  miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma , 2019, Bioscience reports.

[6]  John C. Dawson,et al.  Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas , 2019, Scientific Reports.

[7]  Yuanxi Wang,et al.  MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression , 2019, Acta biochimica et biophysica Sinica.

[8]  S. Patrick,et al.  Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling , 2018, Cancers.

[9]  R. J. Gooding,et al.  MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma. , 2018, Cellular signalling.

[10]  Y. Quan,et al.  Expression of miRNA-206 and miRNA-145 in breast cancer and correlation with prognosis , 2018, Oncology letters.

[11]  Z. Sápi,et al.  The oncomir face of microRNA-206: A permanent miR-206 transfection study , 2018, Experimental biology and medicine.

[12]  A. Lánczky,et al.  Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets , 2018, Scientific Reports.

[13]  N. Bowden,et al.  Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment. , 2018, Endocrine-related cancer.

[14]  C. Zhai,et al.  MicroRNA-206 Protects against Myocardial Ischaemia-Reperfusion Injury in Rats by Targeting Gadd45β , 2017, Molecules and cells.

[15]  Xiao-Yu Zhang,et al.  Myocardin inhibited the gap protein connexin 43 via promoted miR-206 to regulate vascular smooth muscle cell phenotypic switch. , 2017, Gene.

[16]  C. Peng,et al.  MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2 , 2016, Oncotarget.

[17]  Ning Wang,et al.  Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer , 2016, Chinese medical journal.

[18]  K. Mitchelson,et al.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. , 2015, World journal of biological chemistry.

[19]  Wei Zhang,et al.  Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer. , 2015, International journal of clinical and experimental pathology.

[20]  You Li,et al.  MiR-206, a Key Modulator of Skeletal Muscle Development and Disease , 2015, International journal of biological sciences.

[21]  Henan Zhao,et al.  Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer. , 2015, Oncology reports.

[22]  Yan Wang,et al.  Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma. , 2014, Oncology reports.

[23]  Elizabeth Flate,et al.  Motility of select ovarian cancer cell lines: Effect of extracellular matrix proteins and the involvement of PAK2 , 2014, International journal of oncology.

[24]  F. Wan,et al.  MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells , 2014, International journal of molecular medicine.

[25]  X. Tong,et al.  Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT. , 2014, Oncology reports.

[26]  J. Chan,et al.  The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. , 2014, Gynecologic oncology.

[27]  M. Fabbri,et al.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.

[28]  Wen-Wei Chang,et al.  Salmonella enhance chemosensitivity in tumor through connexin 43 upregulation , 2013, International journal of cancer.

[29]  E. Berns,et al.  miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells , 2013, Oncogene.

[30]  Hong Zheng,et al.  Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer , 2013, Cancer biology & medicine.

[31]  Christopher Korch,et al.  DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. , 2012, Gynecologic oncology.

[32]  Hongjing Wang,et al.  Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. , 2012, Oncology reports.

[33]  N. Seki,et al.  microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers , 2012, Oncotarget.

[34]  G. Fu,et al.  MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance , 2011, Journal of Cell Science.

[35]  H. Heneghan,et al.  Circulating miRNA signatures: promising prognostic tools for cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  S. Rosenwald,et al.  Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. , 2009, Gynecologic oncology.

[37]  N. Kondo,et al.  miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. , 2009, Cancer research.

[38]  Bo Song,et al.  Reduction of Orc6 Expression Sensitizes Human Colon Cancer Cells to 5-Fluorouracil and Cisplatin , 2008, PloS one.

[39]  Joel Greshock,et al.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. , 2008, Cancer research.

[40]  A. Addario,et al.  Role of microRNAs in drug-resistant ovarian cancer cells. , 2008, Gynecologic oncology.

[41]  N. Auersperg,et al.  Activin Receptor-Like Kinase 7 Induces Apoptosis through Up-Regulation of Bax and Down-Regulation of Xiap in Normal and Malignant Ovarian Epithelial Cell Lines , 2006, Molecular Cancer Research.

[42]  B. Tsang,et al.  Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[44]  H E Lambert,et al.  Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  D. Alberts,et al.  Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Jing Zhou,et al.  High Expression of miR-206 Predicts Adverse Outcomes：A Potential Therapeutic Target for Esophageal Cancer. , 2019, Combinatorial chemistry & high throughput screening.

[47]  Z. Shao,et al.  Hsa-miR-206 represses the proliferation and invasion of breast cancer cells by targeting Cx43. , 2015, European review for medical and pharmacological sciences.

[48]  X. Wan,et al.  Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma. , 2012, Cancer letters.

[49]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..